These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 30772178

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Off-label use of recombinant activated factor VII in intractable haemorrhage after cardiovascular surgery: an observational study of practices in 23 French cardiac centres (2005-7).
    Hacquard M, Durand M, Lecompte T, Boini S, Briançon S, Carteaux JP.
    Eur J Cardiothorac Surg; 2011 Dec; 40(6):1320-7. PubMed ID: 21550261
    [Abstract] [Full Text] [Related]

  • 23. Use of recombinant activated factor VII concentrate to control postoperative hemorrhage in complex cardiovascular surgery.
    Bowman LJ, Uber WE, Stroud MR, Christiansen LR, Lazarchick J, Crumbley AJ, Kratz JM, Toole JM, Crawford FA, Ikonomidis JS.
    Ann Thorac Surg; 2008 May; 85(5):1669-76; discussion 1676-7. PubMed ID: 18442563
    [Abstract] [Full Text] [Related]

  • 24. [Efficacy of recombinant activated factor VII for massive bleeding after cardiac surgery: experience with 32 patients].
    Millán C, Quintana B, Rodríguez A, Iglesias M, Barranco M, Navia J.
    Rev Esp Anestesiol Reanim; 2009 Oct; 56(8):485-92. PubMed ID: 19994617
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Decreasing the need for transfusion: infant cardiac surgery using hemodilution and recombinant factor VIIa.
    Winch PD, Naguib AN, Bradshaw JR, Galantowicz M, Tobias JD.
    Pediatr Cardiol; 2013 Jan; 34(1):119-24. PubMed ID: 22760694
    [Abstract] [Full Text] [Related]

  • 28. Increased recombinant activated factor VII use and need for surgical reexploration following a switch from aprotinin to epsilon-aminocaproic acid in infant cardiac surgery.
    Scott JP, Costigan DJ, Hoffman GM, Simpson PM, Dasgupta M, Punzalan R, Berens RJ, Tweddell JS, Stuth EA.
    J Clin Anesth; 2014 May; 26(3):204-11. PubMed ID: 24809789
    [Abstract] [Full Text] [Related]

  • 29. Comparison of Fresh-Frozen Plasma, Four-Factor Prothrombin Complex Concentrates, and Recombinant Factor VIIa to Facilitate Procedures in Critically Ill Patients with Coagulopathy from Liver Disease: A Retrospective Cohort Study.
    Kwon JO, MacLaren R.
    Pharmacotherapy; 2016 Oct; 36(10):1047-1054. PubMed ID: 27547916
    [Abstract] [Full Text] [Related]

  • 30. Safety of recombinant factor VIIa in patients under extracorporeal membrane oxygenation.
    Anselmi A, Guinet P, Ruggieri VG, Aymami M, Lelong B, Granry S, Malledant Y, Le Tulzo Y, Gueret P, Verhoye JP, Flecher E.
    Eur J Cardiothorac Surg; 2016 Jan; 49(1):78-84. PubMed ID: 25908783
    [Abstract] [Full Text] [Related]

  • 31. Audit of factor VIIa for bleeding resistant to conventional therapy following complex cardiac surgery.
    McCall P, Story DA, Karalapillai D.
    Can J Anaesth; 2006 Sep; 53(9):926-33. PubMed ID: 16960271
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Use of rFVIIa for critical bleeding in cardiac surgery: dose variation and patient outcomes.
    Willis C, Bird R, Mullany D, Cameron P, Phillips L.
    Vox Sang; 2010 May; 98(4):531-7. PubMed ID: 19878495
    [Abstract] [Full Text] [Related]

  • 34. A multicenter assessment of recombinant factor VIIa off-label usage: clinical experiences and associated outcomes.
    MacLaren R, Weber LA, Brake H, Gardner MA, Tanzi M.
    Transfusion; 2005 Sep; 45(9):1434-42. PubMed ID: 16131375
    [Abstract] [Full Text] [Related]

  • 35. Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery.
    Gill R, Herbertson M, Vuylsteke A, Olsen PS, von Heymann C, Mythen M, Sellke F, Booth F, Schmidt TA.
    Circulation; 2009 Jul 07; 120(1):21-7. PubMed ID: 19546387
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Prophylaxis with recombinant-activated factor VII (rFVIIa) for minimally invasive surgery in a patient with congenital factor VII deficiency: a case report with a single-low dose of rFVIIa.
    Yilmaz AA, Yalcin S, Serdaroglu H, Sonmezer M, Uysalel A.
    Blood Coagul Fibrinolysis; 2008 Oct 07; 19(7):693-5. PubMed ID: 18832912
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.